DWF Labs and DMCC Renew Strategic Agreement to Accelerate Blockchain Innovation in the MENA Region
DWF Labs, a next-generation Web3 market maker and investor, is pleased to announce the renewal of its strategic partnership with DMCC, the leading international business district that drives the flow of global trade through Dubai.
This collaboration reaffirms both parties' commitment to advancing blockchain and Web3 innovation across the Middle East. Since the launch of the partnership, DWF Labs has actively supported the growth of Dubai's crypto ecosystem through its global investment network and market infrastructure expertise.
DWF Labs has invested 7 figures in companies operating out of the DMCC Crypto Centre to date, providing capital and strategic support to founders across multiple verticals within the Web3 space. The renewed agreement focuses on deepening this collaboration by fostering an environment where blockchain startups can access the capital, tools, and mentorship required to scale internationally.
At the heart of this collaboration is the DWF Venture Studio, which continues to serve as a platform for startups within the DMCC Crypto Centre community. The initiative offers advisory support, global market access, and integration pathways to digital asset exchanges, further enabling Web3 founders to navigate both regional and global markets.
With over 650 crypto and blockchain firms now operating out of DMCC, the Crypto Centre has become a vibrant hub for Web3 development in the region. This renewed partnership enhances that ecosystem by extending DWF Labs's global reach, technical insight, and strategic resources to entrepreneurs building from Dubai.
Andrei Grachev, Managing Partner at DWF Labs, commented: 'Our renewed partnership with DMCC reflects a shared vision to make Dubai a launchpad for the next generation of Web3 projects. As the region's ecosystem matures, we are excited to work closely with builders who are driving innovation in digital finance, infrastructure, and applications.'
In November 2024, DWF Labs co-sponsored one of the largest Web3 hackathons in the region, co-hosted by Bybit and DMCC Crypto Centre. The event brought together 15 global Web3 startups building in areas such as tokenisation, AI, Web3 infrastructure and decentralised identity, with the top five projects sharing a USD 160,000 prize pool. The hackathon further demonstrated DWF Labs' hands-on role in supporting DMCC to advance the Web3 ecosystem in Dubai.
Belal Jassoma, Senior Director - Ecosystems (Tech), DMCC, added: 'Our renewed partnership with DWF Labs signals a deepening of our shared commitment to accelerating Web3 innovation in the region. Through the DWF Venture Studio, their global network and active engagement across our ecosystem, startups at the DMCC Crypto Centre gain invaluable access to the tools, mentorship and funding needed to thrive. With over 650 crypto companies now in our community, this collaboration strengthens our ability to support visionary founders as they scale from Dubai to the world.'
This renewed collaboration also aligns with the UAE's Digital Government Strategy 2025, which emphasizes digital-by-design systems, data-driven innovation, and the creation of resilient, future-ready infrastructure.
As Dubai advances its ambition to become a global hub for blockchain and emerging technologies, DWF Labs remains committed to supporting builders who are contributing to this vision through scalable, compliant, and globally competitive Web3 solutions.
About DWF Labs
DWF Labs is the new generation Web3 investor and market maker, one of the world's largest high-frequency cryptocurrency trading entities, which trades spot and derivatives markets on over 60 top exchanges. Learn more: https://www.dwf-labs.com/
About DMCC
DMCC is a leading international business district that drives the flow of global trade through Dubai. We make it easier for our members to do business, helping them access the world's fastest-growing markets from a dynamic district that offers everything they need to thrive. This approach is why we are the preferred location for over 25,000 top multinationals and high-impact startups, contributing significantly to Dubai's position as a global hub for trade and innovation. DMCC is where the world does business.
For more information, visit dmcc.ae.
Contact
VP of Communications
Lynn Chia
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
2 hours ago
- Business Upturn
Lupin launches Ipratropium Bromide Nasal Solution (Nasal Spray) in the US market
Lupin Limited has announced the launch of its generic version of Ipratropium Bromide Nasal Solution in the United States. The product will be available in both 0.03% and 0.06% strengths and is a therapeutic equivalent to Boehringer Ingelheim's Atrovent® Nasal Spray. This launch marks Lupin's latest addition to its U.S. generic portfolio. The Ipratropium Bromide Nasal Solution 0.03% is used to provide symptomatic relief of rhinorrhea linked to both allergic and nonallergic perennial rhinitis in adults and children aged six and above. The 0.06% version targets rhinorrhea symptoms associated with the common cold or seasonal allergic rhinitis in adults and children aged five and older. According to IQVIA data for the 12 months ending May 2025, the reference drug Atrovent® recorded estimated annual U.S. sales of approximately USD 63 million. With this launch, Lupin aims to tap into the niche respiratory care segment while expanding access to affordable treatment options for patients in the U.S. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Yahoo
4 hours ago
- Yahoo
U.S. Leads North America Syringe Infusion Pumps Market Amid Rising Hospitalizations and Chronic Diseases
The North America Syringe Infusion Pumps Market is projected to grow from USD 645.1 million in 2024 to USD 1.04 billion by 2030, at a CAGR of 8.40%. Key drivers include an increase in chronic diseases and surgeries, technological advancements, and the expansion of home healthcare. The market is bolstered by favorable regulations and major regional growth. North American Syringe Infusion Pumps Market Dublin, July 04, 2025 (GLOBE NEWSWIRE) -- The "North America Syringe Infusion Pumps Market Size, Share & Trends Analysis Report by Disease Indication (Pediatrics/neonatology, Chemotherapy, Diabetes, Gastroenterology), End-use (Hospitals, Homecare), Country with Growth Forecasts, 2025-2030" report has been added to North America Syringe Infusion Pumps Market was valued at USD 645.1 million in 2024, and is projected to reach USD 1.04 billion by 2030, rising at a CAGR of 8.40%. The market is experiencing substantial growth driven by the increasing prevalence of chronic diseases, affecting approximately six in ten adults and necessitating precise, continuous medication delivery for conditions such as cancer and diabetes. The rising number of surgical procedures and ICU admissions further amplifies demand for these pumps, crucial for delivering anesthetics and critical care medications. This is especially true considering the projected increase in U.S. hospitalizations from 36 million in 2025 to 40 million by advancements in smart infusion technologies, including Dose Error Reduction Systems (DERS) and EHR compatibility, are pivotal in enhancing medication safety and efficiency, as North America leads in their adoption. The expanding home healthcare and ambulatory care sectors, fueled by an aging population and cost-containment strategies, are increasing the demand for portable, user-friendly syringe pumps for safe medication delivery outside hospitals. Favorable regulatory environments and reimbursement policies further support the sustained growth and innovation within the America Syringe Infusion Pumps Market Report Highlights: Pediatrics/neonatology held the largest revenue share of over 25% in 2024, owing to the critical need for precise drug delivery for newborns and infants, coupled with advancements in safety technologies and NICU/PICU investments The chemotherapy segment is projected to grow at the fastest CAGR over the forecast period Market growth is fueled by the critical need for precise syringe pump delivery of potent drugs, supported by safety features, and the increasing number of cancer cases. Hospitals dominated the market with around 40.0% of the total revenue share in 2024 due to high demand for precise drug delivery in critical care and diverse applications. Homecare is projected to grow at the fastest CAGR of 8.7% over the forecast period. The U.S. dominated the North American syringe infusion pumps market, supported by the high prevalence of chronic diseases and growing national healthcare expenditure. Companies Featured The major companies featured in this North America Syringe Infusion Pumps market report include: Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED Key Attributes: Report Attribute Details No. of Pages 80 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $645.1 Million Forecasted Market Value (USD) by 2030 $1040 Million Compound Annual Growth Rate 8.4% Regions Covered North America Key Topics Covered: Chapter 1. Methodology and ScopeChapter 2. Executive Summary2.1. Market Outlook2.2. Segment Outlook2.3. Competitive InsightsChapter 3. North America Syringe Infusion Pumps Market Variables, Trends & Scope3.1. Market Lineage Outlook3.2. Market Dynamics3.3. North America Syringe Infusion Pumps Market Analysis Tools3.3.1. Industry Analysis - Porter's3.3.2. PESTEL AnalysisChapter 4. North America Syringe Infusion Pumps Market: Disease Indication Estimates & Trend Analysis4.1. Disease Indication Segment Dashboard4.2. North America Syringe Infusion Pumps Market: Disease Indication Movement Analysis4.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by Disease Indication, 2018 to 2030 (USD Million)4.4. Chemotherapy4.5. Diabetes4.6. Gastroenterology4.7. Analgesia/Pain Management4.8. Pediatrics/Neonatology4.9. Hematology4.10. OthersChapter 5. North America Syringe Infusion Pumps Market: End Use Estimates & Trend Analysis5.1. End Use Segment Dashboard5.2. North America Syringe Infusion Pumps Market: End Use Movement Analysis5.3. North America Syringe Infusion Pumps Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)5.4. Hospitals5.5. Homecare5.6. Others (ASC, Nursing Homes, Rehabilitation Centers)Chapter 6. North America Syringe Infusion Pumps Market: Country Estimates & Trend Analysis6.1. Country Market Dashboard6.2. Country Market Share Analysis, 2024 & 20306.3. North America Syringe Infusion Pumps Market by country: Key Takeaways6.4. U.S.6.5. Canada6.6. MexicoChapter 7. Competitive Landscape7.1. Recent Developments & Impact Analysis, By Key Market Participants7.2. Company/Competition Categorization7.3. Vendor Landscape7.3.1. Key company heat map analysis, 20247.4. Company Profiles Baxter B. Braun Medical Inc. Fresenius Kabi AG ICU Medical, Inc. Micrel Medical Devices SA Boston Scientific Corporation BD Terumo Corporation Moog Inc. IRadimed Corporation CODAN Companies ACROMED For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment North American Syringe Infusion Pumps Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Yahoo
4 hours ago
- Yahoo
SOILBUILD INTERNATIONAL BREAKS NEW GROUND IN VIETNAM WITH SPECTRUM HƯNG YÊN INDUSTRIAL LAUNCH IN 2025
HANOI, Vietnam, July 4, 2025 /PRNewswire/ -- Soilbuild International has officially broken ground on Spectrum Hung Yen, a cutting-edge industrial development spanning over 14.45 hectares in Vietnam's thriving northern province. In a ceremony attended by ambassadors, government officials and industry leaders, the developer signalled its deepening commitment to the region's rapidly expanding manufacturing and logistics sector. With nearly 50 years of experience in Singapore's real estate sector, Soilbuild Group is now expanding its industrial expertise globally through Soilbuild International. The launch of Spectrum Hung Yen marks a key milestone in bringing this vision to Vietnam. Designed with a focus on sustainability, functionality, and adaptability, Spectrum Hung Yen is a next-generation industrial estate. Its strategic location near major highways offers streamlined supply chains and efficient regional distribution — meeting the evolving needs of both local and international manufacturers. A fast-track first phaseSpectrum Hưng Yên will deliver ready-built factories spanning 74,225 sqm of land, with a Gross Floor Area (GFA) of 52,000 sqm in its first phase. Legal clearances and initial groundwork began in June 2024 and the handover is targeted in Q1/2026. This project represents a substantial boost to Hung Yen's foreign direct investment (FDI) inflows, with a total capital commitment of USD 60 million, of which USD 34 million is allocated to phase 1. Ben Ding Khoon Yew, General Director of Soilbuild International Vietnam, shared:"After the success of Spectrum Nghe An, we're excited to launch our next chapter in Vietnam. Hung Yen was chosen for its strong leadership, excellent infrastructure, and investor-friendly policies." He emphasized Soilbuild's confidence in Vietnam as a strategic growth market, backed by a solid track record and growing tenant interest. Designed for tomorrow's industrySpectrum Hung Yen is located just 36km from Hanoi, located at VTK - CN8.1-6 Lot, Clean Industrial Park - Hung Yen province. With recent road and bridge upgrades, travel time has been reduced to under an hour. Blending environmental sustainability with strategic logistics, the Spectrum Hung Yen project has already drawn strong interest from electronics, textile, and automotive-component firms — sectors that contributed over USD 2 billion in FDI to the province in the past year. At the groundbreaking ceremony, Singapore Ambassador to Vietnam, Mr. Jaya Ratnam, emphasized:"The Spectrum Hung Yen project reflects the strong and growing economic partnership between Singapore and Vietnam — a clear testament to investor confidence in Vietnam's long-term potential." Developed by Soilbuild International, the project integrates green building principles, modern architecture, and meticulous project management, aiming to serve both current manufacturers and future-oriented global supply chains. Reinforcing its commitment to sustainable development, Soilbuild was recently awarded 'Excellence in Green Strategy'at the Vietnam Industrial Property Forum (VIPF) 2024. About Soilbuild Group Soilbuild is a leading integrated property group with a strong track record in constructing, developing, and managing an award-winning portfolio of residential and business space properties. With close to 50 years of experience, Soilbuild has successfully developed a diverse range of residential projects, from high-end luxury condominiums to landed homes and conservation houses. For Media Enquiries, please contact Email: spectrum@ Tel: (+84) 0868 522 166 Website: View original content to download multimedia: SOURCE SB (HUNG YEN) COMPANY LIMITED
